tiprankstipranks
Kingworld Medicines Group Ltd. (HK:1110)
:1110
Hong Kong Market

Kingworld Medicines Group Ltd. (1110) Financial Statements

Compare
0 Followers

Kingworld Medicines Group Ltd. Financial Overview

Kingworld Medicines Group Ltd.'s market cap is currently HK$257.76M. The company's EPS TTM is HK$0.057; its P/E ratio is 7.46; and it has a dividend yield of 7.86%. Kingworld Medicines Group Ltd. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 1.08B¥ 957.70M¥ 847.39M¥ 745.38M¥ 977.93M
Gross Profit¥ 280.67M¥ 277.63M¥ 263.60M¥ 280.15M¥ 267.40M
Operating Income¥ 96.81M¥ 72.23M¥ 72.22M¥ 73.65M¥ 76.74M
EBITDA¥ 125.48M¥ 118.07M¥ 116.00M¥ 120.59M¥ 121.61M
Net Income¥ 38.10M¥ 43.54M¥ 51.21M¥ 50.89M¥ 43.43M
Balance Sheet
Cash & Short-Term Investments¥ 194.03M¥ 256.17M¥ 198.41M¥ 261.46M¥ 128.82M
Total Assets¥ 1.34B¥ 1.26B¥ 1.21B¥ 1.26B¥ 1.28B
Total Debt¥ 354.43M¥ 290.68M¥ 238.96M¥ 305.78M¥ 231.82M
Net Debt¥ 180.75M¥ 48.52M¥ 51.03M¥ 54.96M¥ 118.32M
Total Liabilities¥ 638.30M¥ 569.15M¥ 493.19M¥ 576.86M¥ 607.18M
Stockholders' Equity¥ 619.03M¥ 615.58M¥ 616.90M¥ 591.80M¥ 603.34M
Cash Flow
Free Cash Flow¥ -63.25M¥ 93.64M¥ 22.88M¥ 113.66M¥ 112.42M
Operating Cash Flow¥ 42.28M¥ 186.55M¥ 81.20M¥ 123.58M¥ 132.71M
Investing Cash Flow¥ -120.63M¥ -84.05M¥ -50.84M¥ -2.76M¥ -7.68M
Financing Cash Flow¥ 4.37M¥ -51.31M¥ -87.20M¥ 25.03M¥ -174.40M
Currency in CNY

Kingworld Medicines Group Ltd. Earnings and Revenue History

Kingworld Medicines Group Ltd. Debt to Assets

Kingworld Medicines Group Ltd. Cash Flow

Kingworld Medicines Group Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis